Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 October 2018 | Story Rulanzen Martin | Photo Peet van Aardt
iCAN contributes to a decolonised curriculum
Some of the student writers who contributed to the anthology that tells their stories in Sesotho, isiXhosa, isiZulu, English and Afrikaans.


How do you transform the higher education curriculum? You involve the exact people the curriculum is intended for. The book, Initiative for Creative African Narratives (iCAN,) illustrates how decolonisation can be achieved through literature   for students by students.

iCAN is an initiative by the Centre for Teaching and Learning (CTL) at the University of the Free State (UFS) to mentor students in creative and narrative writing. Under the mentorship of Dr Peet van Aardt, project coordinator, and Ace Moloi, author and UFS alumnus, iCAN Volume 1 was recently launched with 47 short stories written by UFS students. 

“The project is a response from the centre for the ever-increasing need for decolonised curricula, steeped in the local cultural perspective of ubuntu,” said Dr Van Aardt.

“This book is an example for how decolonisation can be implemented,” said Prof Francois Stydrom, Senior Director of CTL. The overall aim of the iCAN project is to have the content that materialised from it to be included in the curriculum of first-year students at UFS in the near future.

Book provides multiple voices


Starting in May 2018, CTL presented a series of creative writing workshops on all three of the UFS campuses. “It’s a medium that allows a diverse range of students to express their views and develop their voices as writers,” said Prof Strydom.  

It is a form of empowerment, to pass the baton to students to improve the UFS curriculum by writing and publishing their own stories, thereby contributing to larger bodies of knowledge through their lived experiences.

“I believe we as a university need to enable students so that they move away from just being users to becoming contributors to the curriculum,” Dr van Aardt concluded. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept